Infirst Healthcare gains Granulox rights

3 January 2014 - Deborah Wilkes

Archived

Infirst Healthcare has acquired exclusive marketing rights in the UK, the US and other English-speaking countries to Sastomed's Granulox haemoglobin spray for treating chronic wounds.

Click tags below for more information on topics:

Infirst Healthcare

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: